. 2021 Jun 16;10(7):789–795. doi: 10.1530/EC-21-0209
This work is licensed under a Table 1.
Demographic features of the participants at diagnosis of diabetes.
| Parameters | Standard treatment + telemedicine (n = 168) | Standard treatment (n = 207) | P value |
|---|---|---|---|
| Age (years) | 66.9 ± 12.0 | 64.9 ± 13.1 | 0.116 |
| Sex (Female) | 92 (54.8%) | 108 (52.2%) | 0.617 |
| Serum HbA1c (%) | 9.1 ± 2.2 | 9.3 ± 2.3 | 0.334 |
| Fasting plasma glucose level (mg/dL) | 169 ± 6.3 | 170 ± 6.1 | 0.132 |
| 2-h postprandial plasma glucose level (mg/dL) | 243 ± 34.6 | 239 ± 35.5 | 0.446 |
| Body weight (kg) | 54.9 ± 10.7 | 54.6 ± 11.2 | 0.766 |
| Body height (m) | 1.45 ± 0.07 | 1.46 ± 0.20 | 0.795 |
| Body mass index (kg/m2) | 25.9 ± 4.2 | 25.8 ± 4.8 | 0.837 |
| Systolic blood pressure (mm Hg) | 157 ± 19.5 | 158 ± 19.4 | 0.786 |
| Diastolic blood pressure (mm Hg) | 63.0 ± 9.2 | 63.2 ± 8.1 | 0.817 |
| Serum creatinine (mg/dL) | 0.67 ± 0.19 | 0.68 ± 0.19 | 0.583 |
| Serum alanine transaminase (U/L) | 42.5 ± 29.5 | 41.6 ± 29.8 | 0.788 |
| Plasma triglycerides (mg/dL) | 230 ± 124 | 216 ± 108 | 0.267 |
| Plasma high-density lipoprotein cholesterol (mg/dL) | 57.8 ± 23.3 | 58.5 ± 16.3 | 0.744 |
| Plasma low-density lipoprotein cholesterol (mg/dL) | 124 ± 47.4 | 127 ± 46.3 | 0.575 |
| Metformin dose (mg per day) | 1313 ± 470 | 1345 ± 488 | 0.508 |
Data are expressed as means with standard deviation of the mean for continuous variables and number (percentage) for categorical variables. Variables are compared between groups using independent t-test for continuous variables and Pearson’s χ2-test for categorical variables.
A1c, mm Hg, millimeters of mercury; HbA1c, glycosylated haemoglobin; kg, kilograms; m, meters; mg, milligrams.